TMZ + RT + 5-ALA + LIDU SDT System for Newly Diagnosed Butterfly Glioma

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
This study is assessing the safety and tolerability of 5-ALA- mediated Porphyrin Metabolite Activation (PoMA) with LIDU ultrasound, in patients who have just been diagnosed with bihemispheric (in both sides of the brain) glioblastoma, sometimes called butterfly glioblastoma, before they complete their standard of care chemotherapy and radiation and after their standard of care chemotherapy and radiation while they are receviing their standard of care adjuvant chemotherapy.
Epistemonikos ID: b40c7f9df3c989385b9480d0142ff2511e32caea
First added on: Oct 08, 2026